418 related articles for article (PubMed ID: 8335429)
1. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
[TBL] [Abstract][Full Text] [Related]
2. [Ofloxacin (RU 43280): clinical evaluation in urinary and prostatic infections].
Guibert J; Acar JF
Pathol Biol (Paris); 1986 May; 34(5):494-7. PubMed ID: 3534729
[TBL] [Abstract][Full Text] [Related]
3. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
4. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients.
Moysés Neto M; Costa RS; Reis MA; Ferraz AS; Saber LT; Batista ME; Muglia V; Garcia TM; Figueiredo JF
Clin Transplant; 1997 Oct; 11(5 Pt 1):446-52. PubMed ID: 9361939
[TBL] [Abstract][Full Text] [Related]
5. [Urinary infections in adults: clinical approach and therapeutic indications].
Garini G; Mazzi A
Ann Ital Med Int; 1995; 10(1):25-30. PubMed ID: 7727203
[TBL] [Abstract][Full Text] [Related]
6. Intravenous ciprofloxacin versus ceftazidime for treatment of nosocomial pneumonia and urinary tract infection.
Rapp RP; Billeter M; Hatton J; Young AB; Tibbs PA; Dempsey RJ
Clin Pharm; 1991 Jan; 10(1):49-55. PubMed ID: 1999086
[TBL] [Abstract][Full Text] [Related]
7. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)].
Guibert J; Coppens H; Yvelin C
Pathol Biol (Paris); 1982 Jun; 30(6):353-6. PubMed ID: 6287388
[TBL] [Abstract][Full Text] [Related]
9. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
10. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
Davis C
Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
[TBL] [Abstract][Full Text] [Related]
11. Treatment of infections in non-neutropenic patients with cancer, AIDS, or renal transplant using ciprofloxacin.
Maggiolo F; Bianchi W; Ohnmeiss H
Chemioterapia; 1988 Jun; 7(3):164-8. PubMed ID: 3048728
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of cefmenoxime in urinary tract and prostatic infections].
Guibert J; Acar JF; Destree D; Bryskier A
Pathol Biol (Paris); 1985 May; 33(5):330-4. PubMed ID: 3897962
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Dow G; Rao P; Harding G; Brunka J; Kennedy J; Alfa M; Nicolle LE
Clin Infect Dis; 2004 Sep; 39(5):658-64. PubMed ID: 15356779
[TBL] [Abstract][Full Text] [Related]
14. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort.
Vidal E; Torre-Cisneros J; Blanes M; Montejo M; Cervera C; Aguado JM; Len O; Carratalá J; Cordero E; Bou G; Muñoz P; Ramos A; Gurguí M; Borrell N; Fortún J;
Transpl Infect Dis; 2012 Dec; 14(6):595-603. PubMed ID: 22650416
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of azthreonam in severe urinary tract infections].
Guibert J; Acar JF; Miegi M
Pathol Biol (Paris); 1984 May; 32(5):446-9. PubMed ID: 6377208
[TBL] [Abstract][Full Text] [Related]
16. Oral ciprofloxacin in resistant urinary tract infections.
Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
Parras F; Torroba L; Buzón L; Martínez-Beltrán J; Loza E; Baquero F
Enferm Infecc Microbiol Clin; 1989 May; 7(5):261-5. PubMed ID: 2490722
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
19. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections.
Naber KG; Bartnicki A; Bischoff W; Hanus M; Milutinovic S; van Belle F; Schönwald S; Weitz P; Ankel-Fuchs D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S41-53. PubMed ID: 15037328
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
Quartieri F; Bolognesi S; Sconosciuto F
Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
